Eyal Lifschitz, General Partner and Co-Founder of Peregrine Ventures. On behalf of the Fund, Eyal serves on the Boards of many of the portfolio companies, including Valtech Cardio, NLT Spine, and CardioNova. Prior to founding Peregrine Ventures, Eyal co-founded and led the business development efforts of a number of medical technology companies including PharmaSys (acquired by Elan Corp. NYSE:ELN), ECR (acquired by AVX Corp. NYSE:AVX), Visioncare Ophthalmic Technologies, and BioControl Ltd. From 2003-2007 Eyal also served as a Director of Given Imaging (NASDAQ: GIVN).